Antithrombotic Therapy Following Structural Heart Disease Interventions: Current Status and Future Directions
Interventions in structural heart disease cover many catheter-based procedures for congenital and acquired conditions including valvular diseases, septal defects, arterial or venous obstructions, and fistulas. Among the available procedures, the most common are aortic valve implantation, mitral or t...
Main Authors: | Andreas Mitsis, Michaela Kyriakou, Evi Christodoulou, Stefanos Sakellaropoulos, Panayiotis Avraamides |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2024-02-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/RCM/25/2/10.31083/j.rcm2502060 |
Similar Items
-
Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
by: Anna Olasinska-Wisniewska, et al.
Published: (2019-06-01) -
Outcomes of COMBO therapy for severe mitral regurgitation compared with transcatheter edge-to-edge repair
by: Hiroaki Yokoyama, et al.
Published: (2024-02-01) -
Evaluation of Changes in the Cardiac Function before and after Transcatheter Edge-to-Edge Mitral Valve Repair in Healthy Dogs: Conventional and Novel Echocardiography
by: Kenta Sasaki, et al.
Published: (2021-12-01) -
Non symptomatic atrial septal defect venosus type IVC – SV coexistent with non-obstructed foramen ovale in 78 years old patient – a case report
by: Weronika Sandra Topyła, et al.
Published: (2017-12-01) -
Non symptomatic atrial septal defect venosus type IVC – SV coexistent with non-obstructed foramen ovale in 78 years old patient – a case report
by: Weronika Sandra Topyła, et al.
Published: (2017-12-01)